|
Sensitivity analyses: Estimates of prevalence in target population under different assumptions about the ratio between prevalence in attendees and non-attendees. Rates of attendance: men 42.4 % and women 49.3 %. The Oslo Health Study 2000–2001. |
||||||
| Ratio between prevalence in non-attendees and attendees |
Diabetes |
Percent daily smokers |
Percent BMI ≥ 30 kg/m2 |
Percent HSCL score ≥ 1.85 |
Ratio between prevalence in non-attendees and attendees |
Percent reporting good or excellent health |
|
|
||||||
| Men |
Men |
|||||
| 1.00 |
3.8 |
27.7 |
14.8 |
8.3 |
1.00 |
80.5 |
| 1.10 |
4.0 |
29.3 |
15.7 |
8.8 |
0.90 |
81.4 |
| 1.25 |
4.3 |
31.7 |
16.9 |
9.5 |
0.75 |
74.5 |
| 1.50 |
4.9 |
35.7 |
19.1 |
10.7 |
0.67 |
70.8 |
| 2.00 |
6.0 |
43.7 |
23.3 |
13.1 |
0.50 |
62.9 |
| Women |
Women |
|||||
| 1.00 |
2.6 |
27.8 |
13.5 |
13.2 |
1.00 |
76.2 |
| 1.10 |
2.7 |
29.2 |
14.2 |
13.9 |
0.90 |
72.3 |
| 1.25 |
2.9 |
31.3 |
15.2 |
14.9 |
0.75 |
66.5 |
| 1.50 |
3.3 |
34.8 |
16.9 |
16.5 |
0.67 |
63.5 |
| 2.00 |
3.9 |
41.9 |
20.3 |
19.9 |
0.50 |
56.9 |
Søgaard et al. International Journal for Equity in Health 2004 3:3 doi:10.1186/1475-9276-3-3 |
||||||